These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 660413)
1. [Synthetic studies on cardiovascular agents. IV. Synthesis of fused dihydropyridine derivatives (author's transl)]. Sato Y; Shimoji Y; Fujita H; Mizuno H; Kumakura S Yakugaku Zasshi; 1978 Apr; 98(4):448-65. PubMed ID: 660413 [No Abstract] [Full Text] [Related]
2. [Synthetic studies on cardiovascular agents. III. Syntheses of pyrano-[2,3-c]pyrazolone derivatives (author's transl)]. Sato Y; Shimoji Y; Endo K; Nishino H; Koike H; Kumakura S Yakugaku Zasshi; 1978 Mar; 98(3):335-48. PubMed ID: 650412 [No Abstract] [Full Text] [Related]
3. Studies on dihydropyridines. II. Synthesis of 4,7-dihydropyrazolo[3,4-b]-pyridines with vasodilating and antihypertensive activities. Adachi I; Yamamori T; Hiramatsu Y; Sakai K; Sato H; Kawakami M; Uno O; Ueda M Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3235-52. PubMed ID: 3427707 [No Abstract] [Full Text] [Related]
4. Studies on dihydropyridines. III. Synthesis of 4,7-dihydrothieno [2,3-b]-pyridines with vasodilator and antihypertensive activities. Adachi I; Yamamori T; Hiramatsu Y; Sakai K; Mihara S; Kawakami M; Masui M; Uno O; Ueda M Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4389-402. PubMed ID: 3246006 [No Abstract] [Full Text] [Related]
5. Studies on cardiovascular agents. 6. Synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolo[1,5-a]pyrimidines fused to heterocyclic systems. Sato Y; Shimoji Y; Fujita H; Nishino H; Mizuno H; Kobayashi S; Kumakura S J Med Chem; 1980 Aug; 23(8):927-37. PubMed ID: 7401118 [TBL] [Abstract][Full Text] [Related]
6. [The influence of the ester function on the vasodilating activity of 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridine-3,5-dicarboxylates (author's transl)]. Bossert F; Horstmann H; Meyer H; Vater W Arzneimittelforschung; 1979; 29(2):226-9. PubMed ID: 582135 [TBL] [Abstract][Full Text] [Related]
7. New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect. Meguro K; Aizawa M; Sohda T; Kawamatsu Y; Nagaoka A Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3787-97. PubMed ID: 4092280 [No Abstract] [Full Text] [Related]
17. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent. Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028 [TBL] [Abstract][Full Text] [Related]
18. [Synthetic studies on antihypertensive agents. Synthesis and pharmacological study of substituted-hydralazine-like compounds (author's transl)]. Eguchi Y; Nakajima M; Kaneko S; Ishikawa M Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1978; 12():41-51. PubMed ID: 296817 [No Abstract] [Full Text] [Related]
19. Cyanoamidines. II. Synthesis and pharmacological activity of N-arylalkyl-N'-cyano-3-pyridinecarboxamidines. Nakajima T; Nakajima S; Izawa T; Kashiwabara T; Munezuka Y Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2483-90. PubMed ID: 7697763 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones. Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]